INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 46h ago
HOUSE PTR6h ago
SEC 13F6h ago
ROBINHOOD CHAIN6h ago
SEC FORM 4/Grant or awardVerified data

Frakes James B reported AEMD

Director, CFO/CEO · AETHLON MEDICAL INC · Common Stock

Side
A
Value
—
Shares
42.0K
Price
—
Executed
Oct 8, 2026
Disclosed
Oct 13, 2026
Disclosure timeline5 days from execution to publication · legal deadline 2 business days
Oct 8 executedOct 13, 2026 disclosed

AEMD · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
27/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+13 / 25

No reported dollar value · 66666.7% of prior position

  • Filing timing+6 / 15

    Disclosed 3 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · AEMD

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    27
    LP
    Larosa Steven PChief Medical Officer
    AEMDAETHLON MEDICAL INC
    Grant or award
    		A—
    42.0K sh
    		Oct 8, 2026Oct 15, 2026
    traded Oct 8, 2026
    		+7dSEC FORM 4

    Evidence

    23
    SC
    Shah ChetanDirector
    AEMDAETHLON MEDICAL INC
    Tax withholding
    		F$2,843
    436 sh
    		Sep 30, 2026Oct 15, 2026
    traded Sep 30, 2026
    		+15dSEC FORM 4

    Evidence

    23
    GN
    Gikakis NicolasDirector
    AEMDAETHLON MEDICAL INC
    Tax withholding
    		F$2,843
    436 sh
    		Sep 30, 2026Oct 15, 2026
    traded Sep 30, 2026
    		+15dSEC FORM 4

    Evidence

    23
    BG
    Broenniman Edward GDirector
    AEMDAETHLON MEDICAL INC
    Tax withholding
    		F$1,421
    218 sh
    		Sep 30, 2026Oct 15, 2026
    traded Sep 30, 2026
    		+15dSEC FORM 4

    Evidence

    21
    RA
    Rossetti AngelaDirector
    AEMDAETHLON MEDICAL INC
    Grant or award
    		A$50K
    21.8K sh
    		Apr 17, 2026Apr 21, 2026
    traded Apr 17, 2026
    		+4dSEC FORM 4

    Evidence

    21
    SC
    Shah ChetanDirector
    AEMDAETHLON MEDICAL INC
    Grant or award
    		A$50K
    21.8K sh
    		Apr 17, 2026Apr 21, 2026
    traded Apr 17, 2026
    		+4dSEC FORM 4

    Evidence

    21
    GN
    Gikakis NicolasDirector
    AEMDAETHLON MEDICAL INC
    Grant or award
    		A$50K
    21.8K sh
    		Apr 17, 2026Apr 21, 2026
    traded Apr 17, 2026
    		+4dSEC FORM 4

    Evidence

    21
    BG
    Broenniman Edward GDirector
    AEMDAETHLON MEDICAL INC
    Grant or award
    		A$50K
    21.8K sh
    		Apr 17, 2026Apr 21, 2026
    traded Apr 17, 2026
    		+4dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001683168-26-007822
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Oct 8, 2026
    Published
    Oct 13, 2026
    Ingested by INSIDER
    Nov 5, 02:12 UTC
    Last re-read
    Nov 5, 02:12 UTC

    Extracted facts

    Filer
    Frakes James B
    Role
    Director, CFO/CEO
    Transaction
    Grant or awardAs filed: “A”
    Asset
    AETHLON MEDICAL INC
    Ticker
    AEMD
    Shares
    42.0K
    Price per share
    $0
    Execution date (reported)
    Oct 8, 2026
    Owned after transaction
    42.1K shares
    Days from execution to publication
    5

    What this establishes

    Frakes James B filed this Form 4 reporting a grant or award of AEMD on Oct 8, 2026. It became public on Oct 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director, CFO/CEO
    Frakes James Bcik:0001185553
    Issuer
    AETHLON MEDICAL INCcik:0000882291

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.